Workflow
沪鸽二次递表港交所 弹性体印模材料位列国内品牌榜首
Zhi Tong Cai Jing·2025-08-18 23:02

Core Insights - The article discusses the business operations and market position of Hu Ge, a specialized dental materials company in China, which offers a diverse range of products for various dental applications [3][4]. Industry Overview - In 2024, the dental materials market in China is projected to account for 42.2% of the overall dental medical device market, which includes dental equipment and instruments [3]. - The market is characterized by high fragmentation, indicating numerous players with varying market shares [3]. Company Positioning - Hu Ge holds a 1.3% market share in the Chinese dental materials market by revenue in 2024, making it the largest manufacturer of dental impression materials and one of the largest manufacturers of dental clinical materials in China [3]. - The company has the highest number of CE marks or FDA approvals among domestic manufacturers for dental clinical materials [3]. Product Offering - Hu Ge's product matrix effectively meets diverse clinical needs across various dental specialties, including restorative, implant, endodontics, orthodontics, and pediatric dentistry [3]. - According to Frost & Sullivan, Hu Ge ranks first in China for elastic impression materials and synthetic resin teeth by revenue in 2024, and it is also the leading domestic brand in the global market for elastic impression materials [3]. Sales and Distribution - The company has established a robust sales network supported by a wide range of distributors and dental laboratories, enabling it to serve a broad spectrum of dental medical institutions in China [4]. - Hu Ge's products are certified in over 60 countries and regions, with key overseas markets including Europe, the United States, and Southeast Asia [4]. Financial Performance - The revenue figures for Hu Ge over the years are as follows: approximately 280 million RMB in 2022, 358 million RMB in 2023, 399 million RMB in 2024, and 197 million RMB for the first half of 2025 [4][6]. - The net profit for the same periods was approximately 64 million RMB in 2022, 88 million RMB in 2023, 77 million RMB in 2024, and 26 million RMB for the first half of 2025 [4][6].